CRYO SAVE GROUP : -Save Group N.V.: AGM Resolutions
05/16/2012| 08:45am US/Eastern
Recommend:
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces that all resolutions at today's AGM were passed.
The following timetable will apply to both the cash dividend of 8 euro cents, withholding 15% dividend tax and the dividend in shares. Dividend paid in shares will be charged to the share premium reserve.
| Ex-dividend date | 18 May 2012 |
| Record date | 22 May 2012 |
| Period to opt for dividend in cash or in shares | 18 May 2012 - 1 June 2012 |
| Period for determination dividend rights | 18 May 2012 - 1 June 2012 |
| Announcement exchange ratio (after closure NYSE Euronext Amsterdam) | 1 June 2012 |
| Payment date | 14 June 2012 |
All Ordinary Shares that are on the Group's shareholder register on 22 May 2012 will be entitled to the dividend. Shareholders who do not opt to receive a cash dividend will automatically receive shares.
Paying agent: Kempen & Co N.V.
Enquiries:
| Cryo-Save Group | + 31 (0) 575 548 998 |
| Arnoud van Tulder, Chief Executive Officer | |
| | |
| SPJ Financiėle Communicatie (The Netherlands) | +31 (0)20 647 8181 |
| Kees Jongsma/Leon Melens | |
| Daniel Stewart & Company plc (UK) | + 44 (0) 20 7776 6550 |
| Martin Lampshire | |
| | |
| College Hill (UK) | + 44 (0) 20 7457 2020 |
| Rozi Morris/ Adrian Duffield | |
Free footage is available on www.videobankonline.com:
http://www.videobankonline.com/.
About Cryo-Save (www.cryo-save.com/group:
http://www.cryo-save.com/group)
Cryo-Save, the leading international stem cell storage company and the largest family stem cell bank in Europe, already stores more than 213,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors.
There are already several diseases that can be treated by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on three continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India, South Africa and France (validation in progress).
Click here for PDF press release:
http://hugin.info/143308/R/1612757/513481.pdf
Click here for AGM Presentation:
http://hugin.info/143308/R/1612757/513482.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
HUG#1612757
Recommend :
